InsightsDecisions, Risk & Governance

There is a difference between a leader who survives the meeting and a leader who decides it.

By Uttam Dinodia1 min readView this post on LinkedIn

The board only finds out which one they hired when the pressure arrives.

In October 2000, Anne Mulcahy sat in a Xerox boardroom while advisors told her the only sensible option was Chapter 11. The company carried $18 billion in debt, six years of losses, an SEC investigation, and a stock that had fallen 88%.

Bankruptcy was the survival move. Wall Street expected it.

She refused. She fired the accountants who would not acknowledge the books were wrong, walked into Citigroup to ask Sandy Weill to call the two banks holding out on refinancing, and protected the R&D budget every advisor told her to cut.

By 2003, Xerox was profitable. By 2004, it cleared $859 million.

The year Mulcahy took the job, Jim Collins published Level 5 Leadership in Harvard Business Review (2001). The leaders who built enduring companies combined personal humility with professional will. Not charisma. Not certainty. Conviction without ego.

The framework has critics. Survivorship bias is real, and humility without will collapses into softness, but the diagnosis holds:

  • Humility makes you ask for help and listen.
  • Will makes you refuse the option everyone in the room has already chosen.

In 2025, S&P 500 CEO turnover hit 12.5%, above the 25-year average of 11% (Conference Board, 2025). Many of those replacements were rewarded for surviving the quarter, not for deciding the decade.

The entire job of leadership is knowing which moments need surviving and which need deciding.

Conviction is not certainty. It is the refusal to outsource the hard call to whoever wrote the deck.

Where in your current plan are you choosing survival when conviction is the real call?

Uttam Dinodia

Uttam Dinodia

Pharmaceutical Business Consultant & Executive Director, A One Afro Limited

Over 22 years in pharmaceutical supply. Helps international manufacturers and Zambian institutions with public tenders, ZAMRA regulatory pathways and distribution.